98%
921
2 minutes
20
Enhanced Recovery After Surgery (ERAS) protocols aim to improve perioperative outcomes and expedite recovery across various surgical specialties. While ERAS protocols have shown significant benefits in gastrointestinal and cardiovascular surgeries, their impact and effectiveness require further synthesis. This systematic review and meta-analysis evaluated the efficacy of ERAS protocols in enhancing recovery and reducing complications in gastrointestinal and cardiovascular surgeries. High-quality studies were selected based on adherence to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and quality assessment using the Newcastle-Ottawa Scale (NOS). A systematic review and meta-analysis of six high-quality studies involving 45,678 patients were conducted using databases such as PubMed, MEDLINE, EMBASE, and Cochrane Central. Data on length of hospital stay (LOS), complications, 30-day readmissions, and mortality were extracted. Statistical analysis employed random-effects models to calculate pooled effect sizes, odds ratios (ORs), and hazard ratios. Subgroup analyses were performed based on surgery type, patient age, comorbidities, and follow-up duration. ORs for postoperative complications varied across subgroups (e.g., urgent vs. elective surgeries), with some ranges (e.g., 0.65-1.02) reflecting mixed effects; sensitivity analyses confirmed the robustness of pooled outcomes. Recovery times ranged from 1 to 3 days for gastrointestinal surgeries and 4 to 9 days for cardiovascular surgeries, demonstrating clinically meaningful variability. ERAS protocols showed greater recovery benefits in urgent surgeries (HR = 1.42, 95% CI: 1.15-1.75) and in patients with comorbidities (HR = 1.62, 95% CI: 1.33-1.96), likely due to their emphasis on rapid stabilization of perioperative care, including early mobilization and nutritional support. Heterogeneity, assessed through sensitivity analyses, ranged from moderate to substantial across subgroup analyses. ERAS protocols consistently enhance recovery outcomes, minimize complications, and reduce hospital stays in gastrointestinal and cardiovascular surgeries, demonstrating their utility in optimizing perioperative care. Future research should explore long-term outcomes and tailored implementation strategies to address patient-specific needs.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11791094 | PMC |
http://dx.doi.org/10.7759/cureus.76893 | DOI Listing |
Eur J Anaesthesiol
September 2025
From the Department of Anaesthesiology, Intensive Care Medicine, Emergency Medicine and Multidisciplinary Pain Centre, Ziekenhuis Oost-Limburg, Genk (WR, DM, IM, HS, ST), Department of Anaesthesiology, University Hospitals Leuven (WR, SR), Department of Cardiovascular Sciences, KU Leuven, Leuven (WR
Postoperative fatigue (POF) and perioperatively acquired muscle weakness (POAW) are significant yet often under-recognised interlinked postoperative complications that can significantly hinder postoperative recovery and diminish overall quality of life after surgery. Despite advancements in surgical and anaesthetic techniques and the widespread implementation of Enhanced Recovery After Surgery (ERAS) protocols, these conditions remain prevalent. In the weeks following surgery, reported incidences of fatigue of any severity range from 10% to as high as 90%, depending on the patient population.
View Article and Find Full Text PDFFront Surg
August 2025
Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Background: In recent years, global cholecyst-related disorders have been increasing daily. Laparoscopic cholecystectomy (LC) is an advanced gallbladder surgical technique. However, pneumoperitoneum and various factors leading to abdominal distension and other gastrointestinal dysfunctions are common postoperative complications.
View Article and Find Full Text PDFCureus
September 2025
General Surgery, Norfolk and Norwich University Hospital, Norwich, GBR.
Enhanced recovery after surgery (ERAS) protocols are increasingly used in total hip and knee arthroplasty to improve outcomes, reduce complications, and shorten hospital stays. This involves a multidisciplinary, evidence-based approach covering the preoperative to postoperative period. This review explores the current literature on ERAS implementation in elective total hip arthroplasty (THA) and total knee arthroplasty (TKA), focusing on clinical outcomes such as length of stay (LOS), opioid use, complications/readmissions, and other key components such as anesthetic standardization, use of opioid-sparing analgesia agents, early mobilization, and patient satisfaction.
View Article and Find Full Text PDFClin Obstet Gynecol
September 2025
Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI.
Enhanced Recovery After Surgery (ERAS) protocols have been implemented across multiple surgical specialties, including OB/GYN, to improve patients' perioperative experiences. ERAS protocols typically include multimodal pain regimens; opioids are frequently utilized. In the perioperative setting, nonopioid analgesics, including acetaminophen, NSAIDs, dexamethasone, gabapentinoids, ketamine, antidepressants, and local anesthesia may be used, which impacts perioperative opioid utilization.
View Article and Find Full Text PDFBr J Anaesth
September 2025
Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.
Background: Despite widespread adoption of ketamine into enhanced recovery after surgery (ERAS) protocols, research regarding its specific impact on perioperative outcomes is limited. This pragmatic, randomised, double-blind, placebo-controlled, single-cluster trial evaluated the impact of ketamine on postoperative outcomes in patients undergoing major abdominal surgery within an established ERAS protocol.
Methods: Male and female patients, aged ≥18 yr, were randomised to ketamine or saline placebo bolus at induction of general anaesthesia, followed by an intraoperative and postoperative infusion for 48 h.